JoAnn Lindenfeld, MD is a Professor of Medicine in the Department of Medicine and Medical Director of Heart Failure and Heart Transplantation at Vanderbilt University Medical Center in Nashville, TN. She completed her medical degree at the University of Michigan Medical School in Ann Arbor, MI and her cardiology fellowship at the University of Texas in San Antonio, TX. Dr. Lindenfeld is currently a member of the steering committee for four national and international trials, including COAPT, FIX-HF, Parachute, and CAT-HF. She has served on the Food and Drug Administrations (FDA) Cardiorenal Advisory Panel for 8 years, the Cardiovascular Devices Panel for 4 years, and continues to be an ad hoc member of both panels. She was Chair of the Heart Failure Society of America Clinical Practice Guidelines published in 2006 and 2010, served as Vice-President of the Heart Failure Society of America from 2012 to 2014, and President of the Heart Failure Society of America 2015-2016. She is a member of the Heart Failure Society of America, a Fellow of the American Heart Association, a Fellow of the American College of Cardiology, a member of the American Society of Transplantation, and a member of the International Society of Heart and Lung Transplantation. Dr. Lindenfeld has authored more than 200 manuscripts, 18 book chapters, and 22 invited reviews. Her work has informed national policy makers on the treatment of heart failure and the implementation of heart transplantation and mechanical circulatory support.